- Home
- MGTX vs PACB Comparison
MGTX vs PACB Comparison
Compare MGTX & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- PACB
- Stock Information
- Founded
- MGTX 2015
- PACB 2000
- Country
- MGTX United States
- PACB United States
- Employees
- MGTX N/A
- PACB N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- MGTX Health Care
- PACB Industrials
- Exchange
- MGTX Nasdaq
- PACB Nasdaq
- Market Cap
- MGTX 479.9M
- PACB 568.0M
- IPO Year
- MGTX N/A
- PACB 2010
- Fundamental
- Price
- MGTX $6.26
- PACB $1.64
- Analyst Decision
- MGTX Strong Buy
- PACB Buy
- Analyst Count
- MGTX 2
- PACB 13
- Target Price
- MGTX $23.50
- PACB $2.92
- AVG Volume (30 Days)
- MGTX 337.9K
- PACB 9.1M
- Earning Date
- MGTX 03-13-2025
- PACB 02-13-2025
- Dividend Yield
- MGTX N/A
- PACB N/A
- EPS Growth
- MGTX N/A
- PACB N/A
- EPS
- MGTX N/A
- PACB N/A
- Revenue
- MGTX $13,929,000.00
- PACB $173,147,000.00
- Revenue This Year
- MGTX N/A
- PACB N/A
- Revenue Next Year
- MGTX $1,391.84
- PACB $21.56
- P/E Ratio
- MGTX N/A
- PACB N/A
- Revenue Growth
- MGTX 108.24
- PACB 2.14
- 52 Week Low
- MGTX $3.85
- PACB $1.16
- 52 Week High
- MGTX $7.37
- PACB $7.50
- Technical
- Relative Strength Index (RSI)
- MGTX 53.41
- PACB 37.69
- Support Level
- MGTX $5.66
- PACB $1.59
- Resistance Level
- MGTX $6.12
- PACB $2.22
- Average True Range (ATR)
- MGTX 0.39
- PACB 0.17
- MACD
- MGTX -0.02
- PACB -0.04
- Stochastic Oscillator
- MGTX 62.26
- PACB 7.94
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.